scanX
Home
Gufic BioSciences

Gufic BioSciences

382.35
-4.70
(-1.21%)
Market Cap (₹ Cr.)
₹3,865
52 Week High
434.00
Book Value
₹
52 Week Low
237.35
PE Ratio
44.77
PB Ratio
7.26
PE for Sector
38.75
PB for Sector
4.65
ROE
22.92 %
ROCE
18.19 %
Dividend Yield
0.03 %
EPS
₹8.59
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-11.39 %
Net Income Growth
-16.84 %
Cash Flow Change
-194.55 %
ROE
-35.65 %
ROCE
-56.06 %
EBITDA Margin (Avg.)
2.46 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
36
38
52
56
57
55
65
65
63
61
77
90
80
79
93
88
95
93
88
101
88
62
131
167
133
252
194
174
162
166
176
178
174
196
215
202
196
204
Expenses
33
34
47
51
51
49
58
58
59
53
66
77
70
70
80
76
79
80
76
86
75
57
99
139
108
205
158
139
130
132
142
143
141
160
176
165
161
167
EBITDA
3
4
5
6
6
6
7
7
4
9
11
13
10
9
13
12
16
13
12
15
14
4
32
27
24
47
36
34
33
34
33
35
33
36
40
37
35
37
Operating Profit %
8 %
10 %
8 %
10 %
11 %
11 %
10 %
10 %
5 %
12 %
13 %
14 %
11 %
11 %
13 %
14 %
14 %
13 %
12 %
12 %
14 %
6 %
23 %
16 %
18 %
18 %
18 %
19 %
20 %
20 %
19 %
19 %
19 %
18 %
18 %
18 %
18 %
18 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
3
2
4
4
5
3
4
4
4
4
5
4
5
6
6
4
4
4
4
4
Interest
1
1
1
1
2
1
1
2
2
2
3
2
3
2
2
2
3
3
4
3
4
3
4
4
3
1
2
1
1
1
2
2
3
4
4
3
4
5
Profit Before Tax
1
2
3
3
4
4
4
4
1
6
7
10
7
6
10
9
11
9
6
9
6
-3
23
20
17
42
30
29
26
28
27
27
24
28
31
30
27
28
Tax
0
1
1
1
1
2
2
1
2
2
3
4
3
2
3
3
3
4
0
3
-0
0
4
5
2
11
8
7
7
7
8
7
6
7
5
7
7
7
Net Profit
1
1
2
2
2
3
3
3
1
4
6
6
1
4
6
6
6
7
4
7
5
-1
17
15
13
31
23
21
20
21
20
20
18
21
23
22
20
21
EPS in ₹
0.14
0.13
0.21
0.31
0.29
0.33
0.34
0.40
0.10
0.46
0.71
0.75
0.13
0.47
0.79
0.76
0.77
0.88
0.55
0.90
0.51
-0.15
1.79
1.60
1.33
3.22
2.41
2.17
2.09
2.17
2.09
2.10
1.87
2.13
2.39
2.23
2.00
2.08
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
127
152
178
238
280
408
392
521
861
1,093
Fixed Assets
25
22
22
23
24
83
100
115
160
159
Current Assets
91
120
143
198
233
273
261
321
464
600
Capital Work in Progress
0
0
0
2
10
31
13
41
170
307
Investments
0
0
0
0
0
0
0
0
1
2
Other Assets
102
130
156
213
245
294
279
365
531
625
Total Liabilities
100
118
141
184
204
278
219
252
513
560
Current Liabilities
84
104
128
169
186
240
164
186
288
372
Non Current Liabilities
17
15
13
15
18
38
55
66
225
188
Total Equity
27
34
37
54
75
129
173
269
348
533
Reserve & Surplus
19
26
30
46
68
120
164
259
338
523
Share Capital
8
8
8
8
8
10
10
10
10
10
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
4
-0
-1
1
-0
0
2
5
17
-27
Investing Activities
-2
-1
-5
-9
-13
-43
-7
-95
-191
-102
Operating Activities
11
-4
-4
-5
5
47
87
106
-27
-7
Financing Activities
-5
5
7
14
8
-4
-79
-6
234
82
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
65.75 %
65.13 %
75.48 %
75.48 %
75.48 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
72.51 %
72.51 %
72.51 %
72.51 %
FIIs
0.23 %
0.14 %
1.52 %
1.69 %
1.51 %
1.38 %
0.06 %
0.16 %
0.72 %
0.70 %
0.72 %
0.72 %
0.47 %
0.12 %
0.23 %
DIIs
8.25 %
3.24 %
2.13 %
1.19 %
1.12 %
1.13 %
1.16 %
1.16 %
1.16 %
1.16 %
1.64 %
1.58 %
1.73 %
2.20 %
2.39 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
25.77 %
31.49 %
20.87 %
21.64 %
21.89 %
22.49 %
23.78 %
23.69 %
23.12 %
23.14 %
22.64 %
25.19 %
25.29 %
25.17 %
24.88 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
Biocon
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
44.90
ATR(14)
Less Volatile
14.53
STOCH(9,6)
Neutral
22.73
STOCH RSI(14)
Oversold
8.99
MACD(12,26)
Bearish
-3.81
ADX(14)
Weak Trend
16.51
UO(9)
Bearish
47.12
ROC(12)
Downtrend And Accelerating
-6.14
WillR(14)
Oversold
-82.66
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.